Rosen Quoted on Product Safety Evaluation

11 January 2012 USA Today News
Foley Partner David Rosen discusses product safety evaluation following the Food and Drug Administration's (FDA) warning of fines and sanctions to Johnson & Johnson for selling faulty insulin pumps and delaying disclosures of injuries to diabetics using two of the company's pumps. He says that proper safety evaluation of a product is continuously conducted throughout its life span, adding that companies can institute safety infrastructures to process, review and classify complaints that may indicate larger issues with a product.

Related Services